Literature DB >> 20693247

The minimal important difference of exercise tests in severe COPD.

M A Puhan1, D Chandra, Z Mosenifar, A Ries, B Make, N N Hansel, R A Wise, F Sciurba.   

Abstract

Our aim was to determine the minimal important difference (MID) for 6-min walk distance (6MWD) and maximal cycle exercise capacity (MCEC) in patients with severe chronic obstructive pulmonary disease (COPD). 1,218 patients enrolled in the National Emphysema Treatment Trial completed exercise tests before and after 4-6 weeks of pre-trial rehabilitation, and 6 months after randomisation to surgery or medical care. The St George's Respiratory Questionnaire (domain and total scores) and University of California San Diego Shortness of Breath Questionnaire (total score) served as anchors for anchor-based MID estimates. In order to calculate distribution-based estimates, we used the standard error of measurement, Cohen's effect size and the empirical rule effect size. Anchor-based estimates for the 6MWD were 18.9 m (95% CI 18.1-20.1 m), 24.2 m (95% CI 23.4-25.4 m), 24.6 m (95% CI 23.4-25.7 m) and 26.4 m (95% CI 25.4-27.4 m), which were similar to distribution-based MID estimates of 25.7, 26.8 and 30.6 m. For MCEC, anchor-based estimates for the MID were 2.2 W (95% CI 2.0-2.4 W), 3.2 W (95% CI 3.0-3.4 W), 3.2 W (95% CI 3.0-3.4 W) and 3.3 W (95% CI 3.0-3.5 W), while distribution-based estimates were 5.3 and 5.5 W. We suggest a MID of 26 ± 2 m for 6MWD and 4 ± 1 W for MCEC for patients with severe COPD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693247      PMCID: PMC5516638          DOI: 10.1183/09031936.00063810

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

1.  Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction.

Authors:  Holger J Schünemann; Lauren Griffith; Roman Jaeschke; Roger Goldstein; David Stubbing; Gordon H Guyatt
Journal:  J Clin Epidemiol       Date:  2003-12       Impact factor: 6.437

2.  Commentary--goodbye M(C)ID! Hello MID, where do you come from?

Authors:  Holger J Schünemann; Gordon H Guyatt
Journal:  Health Serv Res       Date:  2005-04       Impact factor: 3.402

3.  Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire.

Authors:  David H Kupferberg; Robert M Kaplan; Donald J Slymen; Andrew L Ries
Journal:  J Cardiopulm Rehabil       Date:  2005 Nov-Dec       Impact factor: 2.081

4.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients.

Authors:  D A Redelmeier; A M Bayoumi; R S Goldstein; G H Guyatt
Journal:  Am J Respir Crit Care Med       Date:  1997-04       Impact factor: 21.405

Review 5.  Methods to explain the clinical significance of health status measures.

Authors:  Gordon H Guyatt; David Osoba; Albert W Wu; Kathleen W Wyrwich; Geoffrey R Norman
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

6.  Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

Authors:  Milo A Puhan; Judith Garcia-Aymerich; Martin Frey; Gerben ter Riet; Josep M Antó; Alvar G Agustí; Federico P Gómez; Roberto Rodríguez-Roisín; Karel G M Moons; Alphons G Kessels; Ulrike Held
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

7.  The 6-min walk distance: change over time and value as a predictor of survival in severe COPD.

Authors:  V M Pinto-Plata; C Cote; H Cabral; J Taylor; B R Celli
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

8.  Interpretation of treatment changes in 6-minute walk distance in patients with COPD.

Authors:  M A Puhan; M J Mador; U Held; R Goldstein; G H Guyatt; H J Schünemann
Journal:  Eur Respir J       Date:  2008-06-11       Impact factor: 16.671

9.  Responsiveness and minimal important differences for patient reported outcomes.

Authors:  Dennis A Revicki; David Cella; Ron D Hays; Jeff A Sloan; William R Lenderking; Neil K Aaronson
Journal:  Health Qual Life Outcomes       Date:  2006-09-27       Impact factor: 3.186

10.  What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.

Authors:  Stephen J Walters; John E Brazier
Journal:  Health Qual Life Outcomes       Date:  2003-04-11       Impact factor: 3.186

View more
  106 in total

1.  The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension.

Authors:  Stephen C Mathai; Milo A Puhan; Diana Lam; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

2.  A randomised trial of lung sealant versus medical therapy for advanced emphysema.

Authors:  Carolyn E Come; Mordechai R Kramer; Mark T Dransfield; Muhanned Abu-Hijleh; David Berkowitz; Michela Bezzi; Surya P Bhatt; Michael B Boyd; Enrique Cases; Alexander C Chen; Christopher B Cooper; Javier Flandes; Thomas Gildea; Mark Gotfried; D Kyle Hogarth; Kumaran Kolandaivelu; William Leeds; Timothy Liesching; Nathaniel Marchetti; Charles Marquette; Richard A Mularski; Victor M Pinto-Plata; Michael A Pritchett; Samaan Rafeq; Edmundo R Rubio; Dirk-Jan Slebos; Grigoris Stratakos; Alexander Sy; Larry W Tsai; Momen Wahidi; John Walsh; J Michael Wells; Patrick E Whitten; Roger Yusen; Javier J Zulueta; Gerard J Criner; George R Washko
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

Review 3.  Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?

Authors:  Matthew C Miles; James F Donohue; Jill A Ohar
Journal:  Drugs       Date:  2012-02-12       Impact factor: 9.546

Review 4.  Early Trends in Bronchoscopic Lung Volume Reduction: A Systematic Review and Meta-analysis of Efficacy Parameters.

Authors:  Abhishek Kumar; Rajany Dy; Kanwaljit Singh; M Jeffery Mador
Journal:  Lung       Date:  2016-12-22       Impact factor: 2.584

5.  Pulmonary Rehabilitation Improves Outcomes in Chronic Obstructive Pulmonary Disease Independent of Disease Burden.

Authors:  Praful Schroff; Jason Hitchcock; Christopher Schumann; J Michael Wells; Mark T Dransfield; Surya P Bhatt
Journal:  Ann Am Thorac Soc       Date:  2017-01

6.  One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial.

Authors:  Karin Klooster; Jorine E Hartman; Nick H T Ten Hacken; Dirk-Jan Slebos
Journal:  Respiration       Date:  2016-12-15       Impact factor: 3.580

7.  The clinical impact of non-obstructive chronic bronchitis in current and former smokers.

Authors:  Carlos H Martinez; Victor Kim; Yahong Chen; Ella A Kazerooni; Susan Murray; Gerard J Criner; Jeffrey L Curtis; Elizabeth A Regan; Emily Wan; Craig P Hersh; Edwin K Silverman; James D Crapo; Fernando J Martinez; Meilan K Han
Journal:  Respir Med       Date:  2013-11-15       Impact factor: 3.415

8.  Correlation of cardiopulmonary exercise testing parameters with quality of life in stable COPD patients.

Authors:  Mahsa Mirdamadi; Besharat Rahimi; Enayat Safavi; Hamidreza Abtahi; Soheil Peiman
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

9.  Feasibility and effectiveness of a home-based exercise training program before lung resection surgery.

Authors:  Valerie Coats; François Maltais; Sébastien Simard; Eric Fréchette; Lise Tremblay; Fernanda Ribeiro; Didier Saey
Journal:  Can Respir J       Date:  2013 Mar-Apr       Impact factor: 2.409

10.  The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension.

Authors:  Rubina M Khair; Chisom Nwaneri; Rachel L Damico; Todd Kolb; Paul M Hassoun; Stephen C Mathai
Journal:  Ann Am Thorac Soc       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.